0+
Years of Strategic PresenceLife Sciences Strategy & Advisory
Turning Scientific Potential Into Strategic Progress.
LuminaBio Advisory serves as a senior-level partner to ambitious life sciences organizations, aligning scientific discipline, commercial realities, and regulatory frameworks to guide you from opportunity to execution.
0+
Guided Successfully From Concept0
Advanced Therapeutic Entities0M
Estimated Lives Touched GloballyStrategy in Action
Complex Science Demands Clear Strategy.
We guide life sciences leaders through the multi-dimensional intersections of biotechnology. Scientific discovery alone is not enough; true enterprise progress depends on aligning operational models, rigorous clinical roadmaps, and commercial pathways.
By synthesizing scientific breakthroughs with commercial discipline, we transform dense obstacles into predictable, progressive trajectories.
Our Expertise
Guidance at Key Moments of Transformation.
LuminaBio offers targeted strategic guidance and operational roadmaps customized for your unique biological programs. We do not stop at high-level presentations; our experienced advisors roll up their sleeves and work directly alongside teams to establish local operations, pipelines, and structures.
From Strategic Mapping Through Physical Setup Execution
Built for organizations advancing life sciences
Whether advancing a therapeutic program, scaling an innovative technology, preparing for complex regulatory milestones, or strengthening manufacturing and commercial capabilities, our advisory adapts to the priorities of pharmaceutical and biotechnology companies, digital technology and AI developers, and CDMOs.
Align Your Program Priorities ↗Why LuminaBio
Uncompromising FocusWe Make Complexity Actionable.
Scientific Rigor
Evidence-based advice grounded in development science, regulatory expectations, and practical execution.
Commercial Relevance
We connect scientific potential with manufacturability, investment requirements, market need, and long-term asset value.
Principal-Level Judgment
Every engagement is led by experienced advisors with decades of responsibility for complex development, manufacturing, and strategic decisions.
Boardroom Enablement
Complimentary access to the CMC Masterclass.
Learn what must be established at each development stage — from IND/CTA readiness through late-stage development and launch.
The Masterclass is available at no cost. You may also request a private workshop for your team.
Access the CMC Masterclass at no cost.
Enter your details below for complimentary access to the Masterclass, or to request a private workshop for your team.
Our Approach
From Precision Inquiry to Program Execution.
01 / ALIGN
Enterprise & Program Alignment
Define the strategic objectives, value inflection points, decision rights, and success measures that will guide the engagement.
02 / ASSESS
Scientific, Technical & Operational Assessment
Evaluate development maturity, CMC, regulatory, manufacturing, supply, and organizational risks to identify critical gaps, dependencies, and execution constraints.
03 / ARCHITECT
Integrated Strategy & Roadmap
Translate complex evidence into prioritized strategic options, development scenarios, resource requirements, and an executable cross-functional roadmap.
04 / GOVERN
Executive Decisions & Program Governance
Support stage-gate decisions, investment trade-offs, risk ownership, issue escalation, and alignment across internal teams and external partners.
05 / EXECUTE
Embedded Delivery & Lifecycle Support
Remain engaged through implementation with workstream leadership, milestone oversight, partner and CDMO coordination, course correction, and capability building.
Insights Hub
The Perspective Magazine & Field Notes
Better Decisions Begin With Better Questions.
Five foundational questions every biotechnology board and executive committee must ask before allocating capital to high-stakes therapeutic programs.
De-risking the Pre-IND Review Pathway.
Evaluating stability guidelines and critical quality attributes for complex synthesis products prior to major FDA clinical submissions.
Comparability Frameworks for Advanced Modalities.
Managing process modifications and analytical comparability when transitioning from Phase I/II clinical manufacturing to commercial scale.
Engagement Models
How We Work
We organize our engagements to reflect clinical benchmarks rather than hourly delivery. While programs scale, we align directly with target outcomes.
Assess & Architect
A focused senior-level engagement to evaluate the current position, identify critical risks and dependencies, and define a prioritized, actionable path forward.
Typical outcomes may include:
- Scientific, CMC, regulatory, or operational assessment
- Development and manufacturing gap analysis
- Strategic options and decision criteria
- Risk, resource, and investment priorities
- A sequenced implementation roadmap
Embed & Lead
An experienced LuminaBio leader joins your organization as an interim or fractional member of the team, providing continuity, decision support, and hands-on leadership through a critical stage of growth or transformation.
Support may include:
- Interim CMC or Technical Operations leadership
- Cross-functional program governance
- Executive and board-level decision support
- CDMO, partner, and vendor oversight
- Issue resolution, escalation, and course correction
Mobilize & Deliver
A scalable LuminaBio team works alongside your organization to lead and deliver complex, multi-workstream programs - from strategy and planning through implementation, governance, and sustained operational execution.
Programs may include:
- Product development and lifecycle programs
- CMC, manufacturing, and validation readiness
- Facility, capability, or service-line buildout
- Regulatory submission and inspection readiness
- Technology adoption and regulated workflow integration
Principal-led advisoryExperienced Counsel
Strategy Is Only as Valuable as the Judgment and Execution Behind It.
High-value programs bring together strong experts, complex evidence, and competing priorities. The greatest opportunity often lies in connecting those perspectives early - before decisions, dependencies, and execution requirements begin to pull the program in different directions.
At LuminaBio, I help leadership teams create that alignment. Together, we evaluate the evidence, surface the decisions that will shape future value, and build a pathway that is scientifically defensible, operationally realistic, and ready to execute. I stay involved as the work advances, providing continuity of judgment across teams, partners, and critical milestones.
“My role is to bring clarity to complex decisions, establish a path that teams can execute, and provide the senior judgment needed to keep critical programs moving forward.”
Nadya BradyFounder & Managing Director, LuminaBio Advisory
Bring clarity to the decisions shaping your program, platform, or partnership. Work directly with experienced leadership to define the path forward and sustain momentum through execution.
Start a Conversation ↗Corporate Intake
Initiate a Strategic Engagement
Request support for the decision, milestone, or execution challenge that will shape what comes next. LuminaBio provides focused assessments, embedded senior leadership, and integrated teams to help translate complex priorities into executable plans.
contact@luminabioadvisory.com ↗ Switzerland & North America